grant

Rationally designed targeted immunogens to elicit HIV Envelope V2-apex broadly neutralizing antibodies

Organization UNIVERSITY OF PENNSYLVANIALocation PHILADELPHIA, UNITED STATESPosted 17 Jul 2025Deadline 31 May 2030
NIHUS FederalResearch GrantFY2025AIDS VirusAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAddressAdjuvantAdministrative ManagementAdoptive TransferAffinityAnimal ModelAnimal Models and Related StudiesAntibodiesAntibody ResponseAntigenic DeterminantsAntigensApicalApplications GrantsB blood cellsB cellB cellsB-CellsB-LymphocytesB-cellBinding DeterminantsBiomedical EngineeringClinical EvaluationClinical TestingClinical TrialsCollaborationsConsensusCyclic GMPDevelopmentElementsEngineeringEpitopesEvaluation StudiesFoundationsFrequenciesGametesGerm CellsGerm LinesGerm-Line CellsGoalsGrant ProposalsGuanosine Cyclic MonophosphateHIVHIV InfectionsHIV Vaccine Trials NetworkHIV envelopeHIV envelope proteinHIV vaccineHIV-1 vaccineHIV/AIDS VaccinesHIV1 vaccineHTLV-III InfectionsHTLV-III-LAV InfectionsHVTNHealthHumanHuman Immunodeficiency VirusesHuman T-Lymphotropic Virus Type III InfectionsIND FilingIND applicationIND packageIND submissionImmune MonitoringImmunologic MonitoringImmunological MonitoringImmunologyImmunomonitoringInfectionInterventionInvestigational New Drug ApplicationInvestigatorsKI miceKnock-in MouseLAV-HTLV-IIILeadLymphadenopathy-Associated VirusM mulattaM. mulattaMacaca mulattaMacaca rhesusMessenger RNAMiceMice MammalsModelingModern ManMolecularMurineMusNHP modelsOffice of Administrative ManagementPathogenesisPathway interactionsPb elementPolishesProcessProtein EngineeringRegimenReproductive CellsResearch PersonnelResearchersReverse engineeringRhesusRhesus MacaqueRhesus MonkeySHIVScienceSex CellSiteT cell responseT-CellsT-LymphocyteTestingToxicologyTranslatingVaccine DesignVaccinesViralViral DiseasesVirus DiseasesVirus-HIVWorkbasebasesbio-engineeredbio-engineersbioengineeringbiological engineeringbooster dosebooster shotbooster vaccinecGMPchallenge in rhesus macaquesclinical testdeliver vaccinesdesigndesigningdevelop a vaccinedevelop vaccinesdevelopment of a vaccinedevelopmentalevaluate vaccinesgenetic protein engineeringheavy metal Pbheavy metal leadhuman immunodeficiency virus vaccineimmunization strategyimmunogenimmunogenicityin vivoinfected rhesus macaquesinfected rhesus monkeyinfection in rhesus macaquesinfection of rhesus macaquesinitial cellinnovateinnovationinnovativeknockin micemRNAmanufacturemodel of animalmouse modelmurine modelnano particlenano-sized particlenanoparticlenanosized particleneutralizing antibodynew vaccinesnext generation vaccinesnon-human primatenonhuman primatenonhuman primate modelsnovelnovel vaccinespathwaypre-clinicalpreclinicalprogramsprotein designrational designresearch clinical testingresponserhesus challengerhesus macaque challengerhesus monkey infectionsexual cellsimian HIVsimian human immunodeficiency virusskillssuccessthymus derived lymphocytetoolvaccination protocolvaccination strategyvaccine boostvaccine deliveryvaccine developmentvaccine evaluationvaccine protocolvaccine screeningvaccine strategyvaccine testingviral infectionvirtualvirus infectionvirus-induced diseasewelfare
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

OVERALL: PROJECT SUMMARY
Our primary goal in this IPCAVD program is to develop a germline-targeting priming immunogen for the HIV

Envelope V2-apex broadly neutralizing antibody (bnAb) site. We aim to test its ability to activate V2-apex bnAb

precursors in preclinical animal models and manufacture it under GMP standards for human clinical testing.…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Rationally designed targeted immunogens to elicit HIV Envelope V2-apex broadly neutralizing antibodies — UNIVERSITY OF P | Dev Procure